Indeed, a future goal could be to assess the efficacy and safety of combination therapy with the efficient treatment properties of AG added to amyloid- or tau-directed treatments by using NPs as vehicle, following the example of successful treatment combinations for other serious diseases and conditions, such as cancer. The gene discussed is MAPT; the disease is cancer.